Navigation Links
Toxoplasmosis found more severe in Brazil compared to Europe
Date:8/14/2008

Newborns in Brazil are more susceptible to toxoplasmosis than those in Europe, according to a recent study. Researchers based in Austria, Brazil, Denmark, France, Italy, Poland, Sweden, and the United Kingdom studied the disease's ocular effects in children from birth to four years of age. Details are published August 13th in the open-access journal PLoS Neglected Tropical Diseases.

Toxoplasmosis, caused by Toxoplasma gondii, is the most common parasitic disease found in humans around the world. Infection can cause inflammatory lesions at the back of the eye that sometimes affect vision. Previous studies have suggested more severe complications when people acquire the disease in Brazil than in Europe or North America but have not compared patients directly.

For this study, headed by Ruth Gilbert at the Institute of Child Health, University College London, children with congenital toxoplasmosis were identified by routine screening of their mothers during pregnancy or of the newborn soon after birth. Gilbert's group found that Brazilian children had a five times higher risk than European children for developing eye lesions by four years old. Furthermore, lesions in the retina occurred more frequently and were larger in the Brazilian children, and vision was predicted to be compromised in 87% of the Brazilian children, compared to only 29% in the European children.

The authors believe the more severe clinical symptoms in Brazil are due to infection with more virulent genotypes of the parasite that are predominant in Brazil but rarely found in Europe.


'/>"/>

Contact: Mary Kohut
Press@plos.org
415-568-3457
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Indiana U scientists uncover potential key to better drugs to fight toxoplasmosis parasite
2. Michael J. Fox Foundation PD Therapeutics Conference
3. Worlds smallest snake found in Barbados
4. Simian foamy virus found in several people living and working with monkeys in Asia
5. Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinsons Disease
6. W.M. Keck Foundation grant funds reproductive science research
7. W.M. Keck Foundation announces 2008 class of Distinguished Young Scholars in Medical Research
8. Toxic chemicals found in common scented laundry products, air fresheners
9. New population of highly threatened greater bamboo lemur found in Madagascar
10. Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinsons
11. Glenn Foundation for Medical Research commits $5 million to study aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) announced ... Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for BioPlus® ... hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent No. ...
(Date:5/5/2016)... ... 2016 , ... ProMIS Neurosciences (“ProMIS” or the “Company”) today ... has identified a fourth in a series of novel potential therapeutic targets on ... Alzheimer’s disease (AD). , “This discovery is an important milestone in ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... look no further than LaJollaCooks4u, San Diego’s premiere hands-on cooking experience. Offering everything ... to give mom an experience she won’t forget. , Guests that visit LaJollaCooks4u ...
(Date:5/4/2016)... WHIPPANY, N.J. , May 4, 2016 /PRNewswire/ ... evaluating its oncology compound Stivarga ® (regorafenib) ... hepatocellular carcinoma (HCC) has met its primary endpoint ... The study, called RESORCE, evaluated the efficacy and ... disease has progressed after treatment with sorafenib. The ...
Breaking Biology Technology: